What diseases, other than COVID-19, increase transmural dispersion of repolarization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diseases That Increase Transmural Dispersion of Repolarization

Beyond COVID-19, the primary diseases that increase transmural dispersion of repolarization (TDR) include congenital long QT syndrome (LQTS), short QT syndrome (SQTS), Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), end-stage renal disease, and Kawasaki disease with myocarditis.

Inherited Ion Channelopathies

The most well-established conditions are the inherited cardiac channelopathies, which share a common final pathway of amplified TDR leading to sudden cardiac death 1:

Long QT Syndrome (LQTS)

  • LQTS increases TDR through preferential prolongation of action potential duration in M cells 2
  • LQT2 demonstrates greater TDR than LQT1, with median TPE intervals of 112±5 ms versus 91±2 ms respectively 3
  • The mechanism involves selective action potential prolongation in the mid-myocardial layer, creating increased transmural repolarization gradients that set up conditions for reentry and torsades de pointes 2
  • LQT1 patients show abrupt TDR increases at heart rates corresponding to RR intervals of 600-900 ms, while LQT2 patients demonstrate this across a much wider range (600-1400 ms) 3

Short QT Syndrome (SQTS)

  • SQTS patients have significantly elevated TPE/QT ratios (0.28±0.03) compared to controls (0.21±0.02) 4
  • The increased TDR results from preferential abbreviation of action potential duration in either endocardium or epicardium 1
  • These patients also demonstrate reduced autonomic control of TDR, with lesser capacity to change TPE intervals from steady-state to maximal values 4

Brugada Syndrome

  • TDR amplification occurs through selective abbreviation of action potential duration specifically in right ventricular epicardium 1

Catecholaminergic Polymorphic VT (CPVT)

  • The unique mechanism involves reversal of the direction of activation of the ventricular wall, which is responsible for increased TDR 1

Acquired Conditions

End-Stage Renal Disease

  • Both regional and transmyocardial dispersion of ventricular repolarization are significantly increased in end-stage renal disease 5
  • QT dispersion is markedly elevated (46±17 ms versus 26±16 ms in controls, P<0.001) 5
  • Corrected maximum Tp-Te intervals are prolonged (114±23 ms versus 103±23 ms in controls, P=0.023) 5
  • This increased dispersion likely contributes to the high cardiac mortality rate in dialysis patients, as approximately half die from cardiac causes with ventricular arrhythmias as common terminal events 5

Kawasaki Disease with Myocarditis

  • Inflammation in acute Kawasaki disease aggravates heterogeneity of ventricular repolarization, even when myocarditis is asymptomatic 6
  • Tp-e/QT ratio correlates positively with inflammatory markers (CRP level and body temperature) 6
  • Patients with transient coronary artery lesions show significantly higher Tp-e/QT ratios compared to those without coronary involvement 6

Clinical Implications and Mechanisms

The common pathophysiological thread across these conditions is that increased transmural repolarization gradients create the substrate for reentry circuits 2. The trigger for life-threatening arrhythmias typically involves a premature ventricular contraction arising from early afterdepolarizations during the abnormally prolonged repolarization phase 2.

Important Caveats:

  • Not all QT prolongation carries equal arrhythmic risk—heterogeneity of repolarization (increased TDR) appears necessary in addition to QT prolongation to produce arrhythmogenic responses 2
  • Drug-induced LQTS also increases TDR through inhibition of IKr current, though genetic susceptibility plays a role in individual responses 2
  • The TPE/QT ratio >0.28 may indicate increased arrhythmia risk across various conditions 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.